ENTRY       K08775                      KO
NAME        BRCA2, FANCD1
DEFINITION  breast cancer 2 susceptibility protein
PATHWAY     ko03440  Homologous recombination
            ko03460  Fanconi anemia pathway
            ko05200  Pathways in cancer
            ko05212  Pancreatic cancer
DISEASE     H00019  Pancreatic cancer
            H00027  Ovarian cancer
            H00031  Breast cancer
            H00238  Fanconi anemia
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Genetic Information Processing
              Replication and repair
               03440 Homologous recombination
                K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
               03460 Fanconi anemia pathway
                K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
             Human Diseases
              Cancers
               05200 Pathways in cancer
                K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
               05212 Pancreatic cancer
                K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
            Ubiquitin system [BR:ko04121]
             Ubiquitin ligases (E3)
              multi subunit Ring-finger type E3
               BRCC complex
                K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
            Chromosome [BR:ko03036]
             Eukaryotic Type
              Centrosomal proteins
               Centrosome duplication proteins
                Other centrosome duplication proteins
                 K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
            DNA repair and recombination proteins [BR:ko03400]
             Eukaryotic Type
              DSBR (double strand breaks repair)
               HR (homologous recombination)
                Other HR factors
                 K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
               FA (Fanconi anemia) pathway
                Downstream FA components
                 K08775  BRCA2, FANCD1; breast cancer 2 susceptibility protein
GENES       HSA: 675(BRCA2)
            PTR: 452526(BRCA2)
            PPS: 100976403(BRCA2)
            GGO: 101126719(BRCA2)
            PON: 100435800(BRCA2)
            MCC: 721981(BRCA2)
            MCF: 102140332(BRCA2)
            MMU: 12190(Brca2)
            RNO: 360254(Brca2)
            CGE: 100689197(Brca2)
            HGL: 101698015(Brca2)
            TUP: 102491921(BRCA2)
            CFA: 474180(BRCA2)
            AML: 100472854
            FCA: 493878(BRCA2)
            PTG: 102965865(BRCA2)
            BTA: 507069(BRCA2)
            BOM: 102276437(BRCA2)
            PHD: 102315726(BRCA2)
            CHX: 102182417(BRCA2)
            SSC: 100153762(BRCA2)
            CFR: 102515425(BRCA2)
            BACU: 103017905(BRCA2)
            LVE: 103076579(BRCA2)
            ECB: 100064578(BRCA2)
            MYB: 102245665(BRCA2)
            MYD: 102773822(BRCA2)
            PALE: 102896802(BRCA2)
            MDO: 100049015(BRCA2)
            SHR: 100915673(BRCA2)
            OAA: 100079887(BRCA2)
            GGA: 374139(BRCA2)
            MGP: 100542730
            TGU: 100218603(BRCA2)
            FAB: 101819655(BRCA2)
            PHI: 102113036(BRCA2)
            APLA: 101799101(BRCA2)
            FPG: 101912402(BRCA2)
            FCH: 102052685(BRCA2)
            CLV: 102091608(BRCA2)
            ASN: 102383360(BRCA2)
            AMJ: 102560146(BRCA2)
            PSS: 102455975(BRCA2)
            CMY: 102945068(BRCA2)
            ACS: 100554942
            PBI: 103068142(BRCA2)
            XTR: 100038818(brca2)
            DRE: 566758(brca2)
            TRU: 101079601
            MZE: 101485201
            OLA: 101156345
            XMA: 102225954
            LCM: 102351607(BRCA2)
            CMK: 103177244(brca2)
            SPU: 584780(brca2)
            AGA: AgaP_AGAP007032
            AAG: AaeL_AAEL010133 AaeL_AAEL014774
            CQU: CpipJ_CPIJ012893
            AME: 725687(GB17004)
            BMOR: 101737922
            API: 100166339
            PHU: Phum_PHUM580760
            ISC: IscW_ISCW017529
            TSP: Tsp_00590
            SMM: Smp_160680
            NVE: NEMVE_v1g11039
            ATH: AT4G00020(BRCA2(IV)) AT5G01630(BRCA2B)
            ALY: ARALYDRAFT_486909
            CRB: CARUB_v10003335mg
            EUS: EUTSA_v10012491mg EUTSA_v10027627mg
            CIT: 102628548
            CIC: CICLE_v10013403mg
            TCC: TCM_021601
            GMX: 100797849
            PVU: PHAVU_006G005800g
            MTR: MTR_3g083250
            CAM: 101498291
            FVE: 101314804
            PPER: PRUPE_ppa023298mg
            CSV: 101215906 101230245
            RCU: RCOM_0847980
            POP: POPTR_0014s19050g(POPTRDRAFT_573323)
            VVI: 100241398
            SLY: 101244820
            SOT: 102591010
            OBR: 102701484
            BDI: 100832537
            SBI: SORBI_0013s007040(SORBIDRAFT_0013s007040)
            SITA: 101775022
            ATR: s00023p00030650(AMTR_s00023p00030650)
            OLU: OSTLU_26389
            OTA: Ot11g00640
            MIS: MICPUN_62958(BRCA2)
            MPP: MICPUCDRAFT_62866
            CSL: COCSUDRAFT_56086
            CVR: CHLNCDRAFT_59486
            GSL: Gasu_21050
            CCP: CHC_T00003194001
            CNE: CNG03110
            CNB: CNBG1640
            CGI: CGB_G2270W
            PPL: POSPLDRAFT_105553 POSPLDRAFT_91017
            LBC: LACBIDRAFT_159274
            CCI: CC1G_06567
            SCM: SCHCODRAFT_64762
            UMA: UM03200.1
            PGR: PGTG_00693 PGTG_20647
            DDI: DDB_G0293414
            DPP: DICPUDRAFT_75690
            DFA: DFA_00009
            ACAN: ACA1_110350
            TPS: THAPS_263089(BRAC2)
            NGD: NGA_0400600(BRCA2)
            NGR: NAEGRDRAFT_45350
            TVA: TVAG_473090
REFERENCE   PMID:21731065
  AUTHORS   Holloman WK
  TITLE     Unraveling the mechanism of BRCA2 in homologous recombination.
  JOURNAL   Nat Struct Mol Biol 18:748-54 (2011)
REFERENCE   PMID:15115758
  AUTHORS   Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson JY, Moses R, West SC, de Winter JP, Ashworth A, Jones NJ, Mathew CG
  TITLE     Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.
  JOURNAL   Hum Mol Genet 13:1241-8 (2004)
///
